About Theseus Pharmaceuticals
Theseus Pharmaceuticals is a company based in Cambridge (United States) founded in 2017 by Victor Rivera, Wei Sheng Huang, David Dalgarno, and William Shakespeare was acquired by Concentra in December 2023.. Theseus Pharmaceuticals has raised $100 million across 2 funding rounds from investors including Concentra, T. Rowe Price and Orbimed. The company has 19 employees as of December 31, 2021. Theseus Pharmaceuticals operates in a competitive market with competitors including Jazz Pharmaceuticals, Revolution Medicines, Blueprint Medicines, Syndax and C4 Therapeutics, among others.
- Headquarter Cambridge, United States
- Employees 19 as on 31 Dec, 2021
- Founders Victor Rivera, Wei Sheng Huang, David Dalgarno, William Shakespeare
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
$-50.61 M-85as on Dec 31, 2022
-
EBITDA
$-54.09 M-98as on Dec 31, 2022
-
Total Equity Funding
$100 M (USD)
in 2 rounds
-
Latest Funding Round
$100 M (USD), Series B
Apr 13, 2021
-
Investors
Concentra
& 11 more
-
Employee Count
19
as on Dec 31, 2021
-
Acquired by
Concentra
(Dec 22, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Theseus Pharmaceuticals
Theseus Pharmaceuticals has successfully raised a total of $100M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $100 million completed in April 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $100.0M
- First Round First Round
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2021 | Amount | Series B - Theseus Pharmaceuticals | Valuation | Foresite Capital | |
| Jun, 2018 | Amount | Series A - Theseus Pharmaceuticals | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Theseus Pharmaceuticals
Theseus Pharmaceuticals has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Concentra, T. Rowe Price and Orbimed. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location | |
|
Multi-stage investment firm invests in healthcare and life sciences companies
|
Founded Year | Domain | Location | |
|
Multiple investment strategies are pursued by this hedge fund.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Theseus Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Theseus Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Theseus Pharmaceuticals Comparisons
Competitors of Theseus Pharmaceuticals
Theseus Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Revolution Medicines, Blueprint Medicines, Syndax and C4 Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
|
| domain | founded_year | HQ Location |
Selective kinase inhibitors are developed for genomically defined cancers.
|
|
| domain | founded_year | HQ Location |
Targeted therapies for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Theseus Pharmaceuticals
Frequently Asked Questions about Theseus Pharmaceuticals
When was Theseus Pharmaceuticals founded?
Theseus Pharmaceuticals was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Where is Theseus Pharmaceuticals located?
Theseus Pharmaceuticals is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Is Theseus Pharmaceuticals a funded company?
Theseus Pharmaceuticals is a funded company, having raised a total of $100M across 2 funding rounds to date.
How many employees does Theseus Pharmaceuticals have?
As of Dec 31, 2021, the latest employee count at Theseus Pharmaceuticals is 19.
What does Theseus Pharmaceuticals do?
Theseus Pharmaceuticals was founded in 2017 and is based in Cambridge, United States. Focus is placed on the development of kinase inhibitors targeting oncology indications. Drug candidates such as THE-630, a next-generation KIT inhibitor for gastrointestinal stromal tumors, and an EGFR inhibitor for non-small cell lung cancer, are being advanced. Operations center on pharmaceutical research and preclinical activities within the biotechnology sector.
Who are the top competitors of Theseus Pharmaceuticals?
Theseus Pharmaceuticals's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and argenx.
Who are Theseus Pharmaceuticals's investors?
Theseus Pharmaceuticals has 12 investors. Key investors include Concentra, T. Rowe Price, Orbimed, Farallon Capital Management, and Foresite Capital.